Scopus Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in Scopus. This abstract is what is used to create the fingerprint of the publication.
Patrick D Sutphin)
Science Translational Medicine. 2011;3(94):[94ra70].Abstract
Identifying new targeted therapies that kill tumor cells while sparing normal tissue is a major challenge of cancer research. Using a high-throughput chemical synthetic lethal screen, we sought to identify compounds that exploit the loss of the von Hippel-Lindau (VHL) tumor suppressor gene, which occurs in about 80% of renal cell carcinomas (RCCs). RCCs, like many other cancers, are dependent on aerobic glycolysis for ATP production, a phenomenon known as the Warburg effect. The dependence of RCCs on glycolysis is in part a result of induction of glucose transporter 1 (GLUT1). Here, we report the identification of a class of compounds, the 3-series, exemplified by STF-31, which selectively kills RCCs by specifically targeting glucose uptake through GLUT1 and exploiting the unique dependence of these cells on GLUT1 for survival. Treatment with these agents inhibits the growth of RCCs by binding GLUT1 directly and impeding glucose uptake in vivo without toxicity to normal tissue. Activity of STF-31 in these experimental renal tumors can be monitored by [18F] fluorodeoxyglucose uptake by micro-positron emission tomography imaging, and therefore, these agents may be readily tested clinically in human tumors. Our results show that the Warburg effect confers distinct characteristics on tumor cells that can be selectively targeted for therapy.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Isaac Marin-Valencia; Steve K. Cho; Dinesh Rakheja; Kimmo J. Hatanpaa; Payal Kapur; Tomoyuki Mashimo; Ashish Jindal; Vamsidhara Vemireddy; Levi B. Good; Jack Raisanen; et al.NMR in Biomedicine. 2012;25(10):1177-1186:[94ra70].
Patrick J. Pollard; Bradley Spencer-Dene; Deepa Shukla; Kimberley Howarth; Emma Nye; Mona El-Bahrawy; Maesha Deheragoda; Maria Joannou; Stuart McDonald; Alison Martin; et al.Cancer Cell. 2007;11(4):311-319:[94ra70].
Toshinari Yamasaki; Tram Anh T. Tran; Orhan K. Oz; Ganesh V. Raj; Roderich E. Schwarz; Ralph J. DeBerardinis; Xuewu Zhang; James BrugarolasNature Reviews Urology. 2011;8(3):165-171:[94ra70].
Appears in this Document